[Multiple sclerosis--what should be done?].
Major progress in MS-research has been achieved in recent years concerning diagnosis and differential diagnosis, pathogenetic mechanisms and prognostic indicators. Symptomatic treatment and prevention of complications help to improve quality of life and to prolong expected duration of life. Treatment trials intended to influence the course of the disease must still be considered experimental. Comprehensive rehabilitation remains the cornerstone of long-term management in MS. First results of carefully designed placebo-controlled double-blind studies, however, justify the expectation, that more efficient measures to influence the course of the disease will be available in the near future.
Kesselring
J
J
Rehab-Zentrum, Valens.
D003131:Combined Modality Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000276:immunology / Q000534:rehabilitation*; D009460:Neurologic Examination / Q000187:drug effects; D010166:Palliative Care
D007166:Immunosuppressive Agents